Publication | Closed Access

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy

Hematological MalignancyLymphoid NeoplasiaCancer ImmunosurveillanceMedicineImmunologyHematologyAutoimmunityNatural KillerAdult T-cell Leukemia-lymphomaImmunotherapyNatural Killer-like TRadiation OncologyNatural Killer CellsCellular ImmunotherapyHealth Sciences